Patent · US Active

Inhibition of central nervous system effects from smoking and sensory effects from smoking

US10335378B2 · kind B2 · utility

0Cited by

7References

5Claims

0Family size

Assignee

Altria Client Services LLC · US

Inventors

Gerd Kobal · Sandy Hook, US
Justin Heynekamp · Glen Allen, US
Peter Reeh · Erlangen, DE
Munmaya K. Mishra · Manakin, US
Tetyana Kichko · Erlangen, DE

Key dates

Filing date	Mar 13, 2014
Grant date	Jul 2, 2019
Priority date	—
Expiry date	Mar 13, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions and methods of use therefor for reducing the desire to engage in smoking are disclosed. More specifically, the pharmaceutical composition utilizes an active ingredient to reduce the side effects of smoking cessation and to limit the molecular feedback caused by nicotine-mediated activation of acetylcholine receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.